Hap Trading, LLC Takeda Pharmaceutical CO LTD Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$15.03 - $16.32 $3.35 Million - $3.63 Million	222,700 Added 543.45%	263,679 $4.08 Million
Q2 2023 Aug 11, 2023	BUY	$15.57 - $17.11 $638,043 - $701,150	40,979 New	40,979 $643,000
Q2 2022 Aug 12, 2022	SELL	$13.12 - $15.03 $7.14 Million - $8.18 Million	-544,535 Reduced 69.03%	244,276 $3.43 Million
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $8.83 Million - $11 Million	670,365 Added 565.97%	788,811 $10.8 Million
Q3 2021 Nov 10, 2021	BUY	$16.3 - $17.26 $451,542 - $478,136	27,702 Added 30.53%	118,446 $1.94 Million
Q2 2021 Aug 11, 2021	BUY	$16.55 - $18.64 $1.5 Million - $1.69 Million	90,744 New	90,744 $1.53 Million

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.